Technetium Tc-99m tilmanocept Completed Phase 3 Trials for Cancer, Breast / Melanoma Diagnostic

IndicationsStatusPurposePhase
CompletedDiagnostic3
clinicaltrials.gov IdentifierTitleDrugs
NCT01106040Breast and Melanoma Trial With Lymphoseek to Identify Lymph Nodes